BBIO

NASDAQStock

BridgeBio Pharma, Inc.

$68.82-2.76 (-3.87%)

52-Week Range

$30.14
$79.91

Key Stats

Market Cap

13.3B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Volume

1.6M

Avg Volume

3.3M

Performance

1M

-1.49%

3M

-5.00%

6M

+38.70%

YTD

-8.75%

1Y

+119.05%

3Y

+391.33%

5Y

+2.15%

Price Chart

ETF Exposure

BBIO is held by 120 ETFs

ETFFund NameWeight
QQJGInvesco ESG NASDAQ Next Gen 100 ETF0.24%
URTYProShares - UltraPro Russell20000.23%
BBMCJPMorgan BetaBuilders U.S. Mid Cap Equity ETF0.22%
BKMCBNY Mellon US Mid Cap Core Equity ETF0.22%
SMLFiShares U.S. Small-Cap Equity Factor ETF0.22%
FADFirst Trust Multi Cap Growth AlphaDEX Fund0.21%
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.19%
ISCBiShares Morningstar Small-Cap ETF0.18%
JKJiShares Morningstar Small-Cap ETF0.18%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.18%
TNXTT. Rowe Price Innovation Leaders ETF0.18%
VBVanguard Small-Cap ETF0.18%
VHTVanguard Health Care ETF0.17%
FHLCFIDELITY MSCI HEALTH CARE INDEX ETF0.17%
SCDSJPMorgan Fundamental Data Science Small Core ETF0.17%
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.17%
VXFVanguard Extended Market ETF0.17%
AVIEAvantis Inflation Focused Equity ETF0.15%
JHMHJohn Hancock Multifactor Health Care ETF0.11%
WSMLiShares MSCI World Small-Cap ETF0.10%
PTLInspire 500 ETF0.10%
SMMDiShares Russell 2500 ETF0.09%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker ETF0.08%
JHMMJohn Hancock Investments - Multifactor Mid Cap ETF0.07%
HDGProShares - Hedge Replication ETF0.06%
XTiShares Future Exponential Technologies ETF0.06%
IALTiShares Systematic Alternatives Active ETF0.05%
AVUQAvantis U.S. Quality ETF0.04%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.04%
STXGStrive 1000 Growth ETF0.03%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.03%
STSBiShares Factors US Small Blend Style ETF0.03%
DCORDimensional - US Core Equity 1 ETF0.03%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.03%
ESGVVanguard ESG U.S. Stock ETF0.02%
DFAUDimensional - US Core Equity Market ETF0.02%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.02%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.02%
SCHKSchwab 1000 Index ETF0.02%
VTIVanguard Total Stock Market ETF0.02%
SCHBSchwab U.S. Broad Market ETF0.02%
IWViShares Russell 3000 ETF0.02%
VTHRVanguard Russell 3000 ETF0.02%
AVLCAvantis U.S. Large Cap Equity ETF0.02%
DFUSDimensional - US Equity Market ETF0.02%
V3AL.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.01%
DFACDimensional - US Core Equity 2 ETF0.01%
GUSAGoldman Sachs MarketBeta US 1000 Equity ETF0.01%
VTVanguard Total World Stock ETF0.01%
ITDGiShares LifePath Target Date 2055 ETF0.01%
PreviousPage 2 of 3Next

About BBIO ETF Exposure

BridgeBio Pharma, Inc. (BBIO) is held by 120 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 13.3B, BBIO is a widely held institutional stock. The stock currently trades at $68.82. Investors can gain exposure to BBIO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BBIO, sorted by portfolio weight.